Literature DB >> 8787920

TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.

P A Bradford1, N V Jacobus, N Bhachech, K Bush.   

Abstract

TEM-28 (pI 6.1), expressed by an Escherichia coli clinical isolate, is a novel beta-lactamase which hydrolyzed ceftazidime, cefotaxime, and aztreonam with rates of 25, 1.1, and 5.6, respectively, relative to that for benzylpenicillin (100). The nucleotide sequence of blaTEM-28 differed from that of blaTEM-1 by two base changes, resulting in amino acid substitutions of Arg-164 to His and Glu-240 to Lys.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8787920      PMCID： PMC163097     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae.

Authors:  C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  An IS1-like element is responsible for high-level synthesis of extended-spectrum beta-lactamase TEM-6 in Enterobacteriaceae.

Authors:  S Goussard; W Sougakoff; C Mabilat; A Bauernfeind; P Courvalin
Journal:  J Gen Microbiol       Date:  1991-12

3.  Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.

Authors:  L B Rice; S H Willey; G A Papanicolaou; A A Medeiros; G M Eliopoulos; R C Moellering; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 4.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Effective cooling allows sonication to be used for liberation of beta-lactamases from gram negative bacteria.

Authors:  K Bush; S B Singer
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

6.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

7.  Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.

Authors:  A Bauernfeind; G Hörl
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

8.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Authors:  J P Quinn; D Miyashiro; D Sahm; R Flamm; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

10.  New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis.

Authors:  T Palzkill; K S Thomson; C C Sanders; E S Moland; W Huang; T W Milligan
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191
View more
  17 in total

1.  Evolution of TEM-related extended-spectrum beta-lactamases in Korea.

Authors:  H Pai; H J Lee; E H Choi; J Kim; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.

Authors:  Martina Zarnayová; Eliane Siebor; André Péchinot; Jean-Marie Duez; Helena Bujdáková; Roger Labia; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  New TEM-derived extended-spectrum beta-lactamase and its genomic context in plasmids from Salmonella enterica serovar derby isolates from Uruguay.

Authors:  Rafael Vignoli; Nicolas F Cordeiro; Virginia García; María Inés Mota; Laura Betancor; Pablo Power; José A Chabalgoity; Felipe Schelotto; Gabriel Gutkind; Juan A Ayala
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.

Authors:  Frédéric Robin; Julien Delmas; Cédric Schweitzer; Olivier Tournilhac; Olivier Lesens; Catherine Chanal; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

Review 5.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be.

Authors:  L S Tzouvelekis; M Gazouli; E E Prinarakis; E Tzelepi; N J Legakis
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

7.  TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy.

Authors:  M Perilli; B Segatore; M R de Massis; M L Riccio; C Bianchi; A Zollo; G M Rossolini; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.

Authors:  C Hal Jones; Alexey Ruzin; Margareta Tuckman; Melissa A Visalli; Peter J Petersen; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

9.  CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia.

Authors:  P A Bradford; Y Yang; D Sahm; I Grope; D Gardovska; G Storch
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.

Authors:  Anne Marie Queenan; Barbara Foleno; Colleen Gownley; Ellyn Wira; Karen Bush
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.